Influence of CYP2D6, CYP3A5, ABCB1, APOE polymorphisms and nongenetic factors on donepezil treatment in patients with Alzheimer’s disease and vascular dementia

Overview of attention for article published in Pharmacogenomics and Personalized Medicine, September 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 24 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 15 publications that cite this research output.

15

The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.

Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms

Article in Genes (November 2023)

Predictors of response to acetylcholinesterase inhibitors in dementia: A systematic review

Article in Frontiers in Neuroscience (September 2022)

The American Psychiatric Association Publishing Textbook of Geriatric Psychiatry

Monograph (August 2022)